|
2022
|
Invention
|
Crystal form and amorphous form of dezocine analogue hydrochloride. An amorphous form of dezocine... |
|
2021
|
Invention
|
Ssao inhibitor. The present invention provides an SSAO inhibitor and an application thereof in pr... |
|
|
Invention
|
Angiotensin ii receptor 2 antagonist salt form and crystalline form, and preparation method there... |
|
2020
|
Invention
|
Crystal form of sglt inhibitor and application thereof. Crystal form A of a compound represented ... |
|
|
Invention
|
Sglts inhibitor and application thereof. A compound as an SGLT1/SGLT2 dual inhibitor, and an appl... |
|
|
Invention
|
Process for preparing 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1h-benzo[d]im... |
|
2019
|
Invention
|
Process route of compound of formula (iv), crystal form and preparation method therefor. Disclose... |
|
|
Invention
|
2r receptor antagonist. 2R).(II)
|
|
|
Invention
|
Crystal form b of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1h-benzo[d]imidaz... |
|
2018
|
Invention
|
Dezocine analogue ester-containing sustained-release suspension and preparation method therefor. ... |
|
|
Invention
|
Sustained release suspension containing dezocine analogue ester and preparation method therefor. ... |
|
|
Invention
|
Crystal form and amorphous form of dezocine analogue hydrochloride. The present invention relates... |
|
2017
|
Invention
|
Imidazole derivative used as antiviral agent and use thereof in preparation of medicament. Disclo... |
|
|
Invention
|
Dezocine analogue. Disclosed in the present disclosure is a Dezocine analog, and particularly dis... |
|
|
Invention
|
Dezocine analogue. Disclosed in the present invention is a Dezocine analogue, and particularly di... |
|
2016
|
Invention
|
Crystal form a of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1h-benzo [d]imida... |
|
|
Invention
|
Method for preparing imidazole derivative and intermediate thereof and crystal form. Disclosed ar... |
|
2014
|
Invention
|
Imidazole derivative used as antiviral agent and use therof in preparation of medicament. Disclos... |
